Filed Pursuant to Rule 424(b)(5)
Registration No. 333-264352
The information in this preliminary prospectus supplement relates to an effective registration statement under the Securities Act of 1933, as amended but is not complete and may be changed.
Subject to Completion
Preliminary Prospectus Supplement dated November 3, 2022
PROSPECTUS SUPPLEMENT
(To Prospectus dated April 18, 2022)
16,500,000 Shares

VICI Properties Inc.
Common Stock
We expect to enter into forward sale agreements with BofA Securities, Inc. and Citibank, N.A. (or their respective affiliates), who we refer to in this capacity as the forward purchasers. In connection with the forward sale agreements, the forward purchasers, or their respective affiliates, are expected to borrow from third parties and to sell to the underwriters an aggregate of 16,500,000 shares of our common stock, par value $0.01 per share, or our common stock, that will be sold in this offering. We will only receive proceeds, if any, upon settlement of the forward sale agreements, as described below.
We expect to physically settle the forward sale agreements (by the delivery of shares of our common stock) and receive proceeds from the sale of those shares of our common stock on one or more forward settlement dates no later than approximately 12 months after the date of this prospectus supplement. We may also elect to cash settle or net share settle all or a portion of our obligations under the forward sale agreements if we conclude that it is in our best interest to do so. If we elect to cash settle the forward sale agreements, we may not receive any cash proceeds, and we may be required to pay cash to the forward purchasers in certain circumstances. If we elect to net share settle the forward sale agreements, we will not receive any cash proceeds, and we may be required to deliver shares of our common stock to the forward purchasers in certain circumstances. See “Underwriting—Forward Sale Agreements.”
If either forward purchaser or its affiliate does not sell on the anticipated closing date of this offering all of the shares of our common stock that it has agreed to sell to the underwriters after using commercially reasonable efforts, we will issue and sell to the underwriters a number of shares of our common stock equal to the number of shares of our common stock that such forward purchaser or its affiliate does not sell, and the number of shares of our common stock underlying the relevant forward sale agreement will be decreased by the number of shares of our common stock that we issue and sell.
Our common stock is listed on the New York Stock Exchange (the “NYSE”) under the symbol “VICI.” On November 2, 2022, the closing price of our common stock as reported on the NYSE was $32.01 per share.
We have elected to be taxed as a real estate investment trust (“REIT”) for U.S. federal income tax purposes commencing with our taxable year ended December 31, 2017. To assist us in maintaining our status as a REIT, among other purposes, our charter contains certain restrictions relating to the ownership and transfer of our shares and a provision generally restricting stockholders from owning more than 9.8% in value or in number, whichever is more restrictive, of any class or series of our shares, including the common stock offered hereby. In addition to the restrictions referred to in the immediately preceding sentence, ownership of our capital stock, including the common stock offered hereby, is subject to applicable gaming laws, and any person owning or controlling at least 5% of the outstanding shares of any class of our capital stock is required to promptly notify us of their identity. See “Description of Capital Stock—Restrictions on Ownership and Transfer” and “—Redemption of Securities Owned or Controlled by an Unsuitable Person or Affiliate” in the accompanying prospectus for a detailed description of the ownership, transfer and notification restrictions applicable to our common stock.
Investing in our common stock involves risks. You should read carefully and consider the “Risk Factors” beginning on page S-6 of this prospectus supplement and the risk factors described in our Annual Report on Form 10-K for the year ended December 31, 2021 (the “Annual Report”), which is incorporated herein by reference.
Neither the Securities and Exchange Commission nor any state or other securities commission has approved or disapproved these securities or passed upon the accuracy or adequacy of this prospectus supplement. Any representation to the contrary is a criminal offense.
The underwriters have agreed to purchase shares of our common stock at a price of $ per share, which will result in approximately $ million of net proceeds to us after expenses (or approximately $ million if the underwriters exercise their option to purchase additional shares of our common stock in full) from the settlement of the forward sale agreements. The underwriters may offer the shares of our common stock from time to time for sale in one or more transactions on the NYSE, in the over-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices. The amount of proceeds, if any, we may receive upon settlement of the forward sale agreements, which settlement we expect to occur no later than approximately 12 months after the date of this prospectus supplement, depends on numerous factors, including the settlement method, market interest rates and the prevailing market price of our common stock during the relevant period. For the purposes of calculating the aggregate net proceeds to us, we have assumed that the forward sale agreements are fully physically settled in one or more settlements based on an initial forward sale price of $ per share (which is the price at which the underwriters have agreed to purchase the shares of our common stock offered hereby). The forward sale price is subject to adjustment pursuant to the forward sale agreements, and the actual proceeds, if any, to us will be calculated as provided in the forward sale agreements. Although we expect to settle the forward sale agreements entirely by the physical delivery of shares of our common stock in exchange for cash proceeds, we may elect cash settlement or net share settlement for all or a portion of our obligations under the forward sale agreements. We would receive net proceeds of $ per share after expenses for any shares of our common stock that we issue directly to the underwriters because a forward purchaser or its affiliate does not sell all of the shares it is offering hereby. See “Underwriting—Forward Sale Agreements.”
The underwriters have been granted a 30-day option from the date of this prospectus supplement, exercisable in whole or in part from time to time to purchase up to an additional 2,475,000 shares of our common stock at a price of $ per share. Upon any exercise of such option, the number of shares of our common stock underlying the forward sale agreements will be increased by the number of shares sold by the forward purchasers or their respective affiliates in respect of such option exercise. In such event, if the forward purchasers or their respective affiliates do not deliver and sell all of the shares of our common stock to be sold in connection with the exercise of such option, we will issue and sell to the underwriters a number of shares of our common stock equal to the number of shares of our common stock that such forward purchasers or their respective affiliates do not sell, and the number of shares of our common stock underlying the forward sale agreements will be decreased by the number of shares of our common stock that we issue and sell.
The underwriters expect to deliver the shares of our common stock on or about November , 2022 through the facilities of The Depository Trust Company.
| | |
BofA Securities | | Citigroup |
The date of this prospectus supplement is November , 2022